NR3C2 and obesity due to melanocortin 4 receptor deficiency: confirmed the importance of MR blockers to prevent cardiovascular complications and cerebrovascular accidents even in patients with normal values of Aldo (16, 17) and several studies are evaluating a possible terapeuthic role of MR blockers to treat obesity and metabolic disorders (18).